多基因风险评分无创分层非酒精性脂肪性肝病肝细胞癌风险
该研究在NAFLD队列(n=2,566,226例HCC)和UK Biobank队列(n=364,048,202例HCC)中评估基于PNPLA3-TM6SF2-GCKR-MBOAT7及HSD17B13的多基因风险评分(PRS-HFC和PRS-5)对HCC的预测价值。结果显示PRS对HCC的预测优于单变异,且独立于纤维化及经典危险因素,高PRS切点(≥0.532/0.495)在UKBB中检测HCC特异性约90%但敏感性有限。结论支持肝脂肪与HCC的因果关系,PRS可能有助于代谢异常人群的HCC风险分层。
要点
- PRS-HFC和PRS-5对HCC的预测优于单基因变异(p<10-13)。
- PRS与HCC的关联主要由严重纤维化介导,但在无严重纤维化亚组中仍显著(p<0.05)。
- 高PRS切点(≥0.532/0.495)检测HCC特异性约90%,敏感性有限。
核心结论
- 结果支持肝脂肪与HCC之间存在因果关系。
- PRS提高了HCC检测准确性,可能有助于代谢异常人群(包括无严重肝纤维化者)的HCC风险分层。
研究设计与样本
- 研究纳入NAFLD队列(n=2,566,226例HCC)和德国NAFLD复制队列(n=427),以及UK Biobank一般人群队列(n=364,048,202例HCC)。
- 将PNPLA3-TM6SF2-GCKR-MBOAT7变异组合为肝脏脂肪PRS(PRS-HFC),再校正HSD17B13得到PRS-5。
主要发现
- 在NAFLD队列中,遗传风险变异对HCC的校正影响与脂肪肝易感性成比例(p=0.002),效应存在一定异质性。
- PRS预测HCC比单变异更稳健(p<10-13)。
- PRS与HCC的关联主要由严重纤维化介导,但在临床相关亚组中独立于纤维化,且在无严重纤维化者中仍可观察到(p<0.05)。
- 在UKBB队列中,PRS独立于经典危险因素和肝硬化预测HCC(p<10-7)。
- 在NAFLD队列中确定的高PRS切点(PRS-HFC/PRS-5分别为≥0.532/0.495)在UKBB队列中检测HCC特异性约90%但敏感性有限;PRS在肝硬化(p<10-5)和无肝硬化(p<0.05)个体中均预测HCC。
关键数值与推荐
- PRS-HFC高切点≥0.532,PRS-5高切点≥0.495,在UKBB队列中检测HCC特异性约90%,敏感性有限。
临床怎么用
- PRS可在临床中检测,可能帮助对代谢异常人群(包括无严重肝纤维化者)进行HCC风险分层。
- 高PRS切点特异性约90%但敏感性有限,需结合其他临床因素综合评估。
局限性
- 研究结果需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) risk stratification in individuals with dysmetabolism is a major unmet need. Genetic predisposition contributes to non-alcoholic fatty liver disease (NAFLD). We aimed to exploit robust polygenic risk scores (PRS) that can be evaluated in the clinic to gain insight into the causal relationship between NAFLD and HCC, and to improve HCC risk stratification. METHODS: We examined at-risk individuals (NAFLD cohort, n = 2,566; 226 with HCC; and a replication cohort of 427 German patients with NAFLD) and the general population (UK Biobank [UKBB] cohort, n = 364,048; 202 with HCC). Variants in PNPLA3-TM6SF2-GCKR-MBOAT7 were combined in a hepatic fat PRS (PRS-HFC), and then adjusted for HSD17B13 (PRS-5). RESULTS: In the NAFLD cohort, the adjusted impact of genetic risk variants on HCC was proportional to the predisposition to fatty liver (p = 0.002) with some heterogeneity in the effect. PRS predicted HCC more robustly than single variants (p <10-13). The association between PRS and HCC was mainly mediated through severe fibrosis, but was independent of fibrosis in clinically relevant subgroups, and was also observed in those without severe fibrosis (p <0.05). In the UKBB cohort, PRS predicted HCC independently of classical risk factors and cirrhosis (p <10-7). In the NAFLD cohort, we identified high PRS cut-offs (≥0.532/0.495 for PRS-HFC/PRS-5) that in the UKBB cohort detected HCC with ~90% specificity but limited sensitivity; PRS predicted HCC both in individuals with (p <10-5) and without cirrhosis (p <0.05). CONCLUSIONS: Our results are consistent with a causal relationship between hepatic fat and HCC. PRS improved the accuracy of HCC detection and may help stratify HCC risk in individuals with dysmetabolism, including those without severe liver fibrosis. Further studies are needed to validate our findings. LAY SUMMARY: By analyzing variations in genes that contribute to fatty liver disease, we developed two risk scores to help predict liver cancer in individuals with obesity-related metabolic complications. These risk scores can be easily tested in the clinic. We showed that the risk scores helped to identify the risk of liver cancer both in high-risk individuals and in the general population.
引用
- Bianco C, Jamialahmadi O, Pelusi S, et al. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. J Hepatol. 2020. PMID: 33248170. doi:10.1016/j.jhep.2020.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。